Navigation Links
Access Pharmaceuticals Presents New Data at International Symposium Showing Company's Angiolix(R) Monoclonal Antibody has Potential to Treat Cancer by Attacking Cancer Stem Cells
Date:6/26/2008

o numerous risks, including but not limited to Access' need to obtain additional financing in order to continue the clinical trial and operations and to the risks detailed in Access' Annual Report on Form 10-K and other reports filed by Access with the Securities and Exchange Commission.


'/>"/>
SOURCE Access Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. CTI Enters Into Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data for Potential U.S. Supplemental Marketing Application
2. A Perfect Storm Threatens Patient Access to Specialty Medical Care
3. AMT Makes Important Advance in the Development of its Gene Therapy for Hemophilia B -Company Accesses Technology to Prevent Immune Response
4. Access Licenses ProLindac(TM) to Jiangsu Aosaikang Pharmaceutical Co., LTD., a Leading Oncology Pharmaceutical Company for Manufacturing, Development and Commercialization in the Greater China Region
5. HistoRx Announces Expanded Access of AQUA(R) Technology to 900+ Researchers at Dana-Farber/Harvard Cancer Center
6. AMT Accesses Technology for Treatment of Duchenne Muscular Dystrophy
7. Access Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
8. SurgiQuest Announces First Single Port Procedure for Ovary Removal Using AirSeal(TM) Access System
9. Scientists call for more access to biotech crop data
10. Perceptive Informatics Improves Clinical Site Monitoring Access and Flexibility With Portable USB Drive Capability
11. Canadian Centre for DNA Barcoding to Participate in Microchip Biotechnologies Early Access Program for Microchip-Based DNA Sample Preparation and Cycle Sequencing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Nektar Therapeutics (Nasdaq: NKTR ) ... to serve on its board of directors. ... over 35 years of experience in corporate management, ... Nektar extensive industry perspective at an important time ... President and CEO of Nektar and member of ...
(Date:12/11/2009)... ROCKVILLE, Md., Dec. 11 EntreMed, Inc. ... of $1.7 million in royalty revenue from sales ... estimated royalty revenue of $3.3 million. In ... quarter and projected revenue for fiscal 2009. ... the third quarter will be reflected in the ...
(Date:12/11/2009)... College researchers have observed the "hot electron" effect in ... harvested the elusive charges using ultra-thin solar cells, opening ... authors report in the current online edition of ... in solar cells, it generates free electrons in a ... these charges, the electrons must reach the bottom of ...
(Date:12/11/2009)... Mass., Dec. 11 Gwathmey, Inc., ... specializing in cancer, staph aureus, and cardiovascular disease ... Services announced today that Rosalie Dunn, Ph.D., has ... Dunn has over 28 years of experience working ... Prior to joining Gwathmey, Dr. Dunn managed multimillion ...
Breaking Biology Technology:Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3EntreMed Reports Receipt of Third Quarter Royalty Payment 2Elusive 'hot' electrons captured in ultra-thin solar cells 2Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer 2
... Calif., Sept. 8 SuperGen, Inc.,(Nasdaq: SUPG ... rapid,development and commercialization of therapies for solid tumors ... Officer, and Michael V. McCullar, Ph.D., Vice President ... the Merriman 5th,Annual Investor Summit on Monday, September ...
... TAIAN CITY, Shandong, China, Sept. 8 /Xinhua-PRNewswire-FirstCall/ --,China ... Biologic",or the "Company"), one of the leading plasma-based ... today announced that the Company,will present at the ... 10 - 12, 2008 at the Grand Hyatt ...
... and PRINCETON, New Jersey and SAN DIEGO,California, September 8 ... R&D for Continuous Process,Chemistry Technologies and for Further Global ... an investment of $3.3M,by a group of private and ... of Graphisoft and Dave Tapolczay, CEO of Medical,Research Council ...
Other Biology Technology:SuperGen to Present at Merriman 5th Annual Investor Summit on September 15, 2008 2China Biologic Products to Present at the SIG Beijing Management Summit 2China Biologic Products to Present at the SIG Beijing Management Summit 3World Leader in Bench-Top Flow Chemistry Instruments ThalesNano, Inc. Closes Funding Round 2
(Date:12/11/2009)... variability and circulation system could help improve projections of ... more by surface warming than previously thought, and this ... as sea level rise and ice volume changes. , ... result in a more vigorous deep ocean circulation system. ... quantities of warm water, with possible impacts including reduction ...
(Date:12/11/2009)... traditionally been limited by the seasons, particularly ... be short. Thanks to researchers and fruit ... that offer growers the ability to produce ... for both producers and consumers. Fresh examples ... "primocane-fruiting", which bear fruit on current-season canes, ...
(Date:12/11/2009)... German . , Halle/Saale. With increasing ... extinctions, plant communities of many European regions are ... more frequently, whereas rare species are becoming extinct. ... are becoming increasingly similar, but also the phylogenetic ... a loss of uniqueness among European floras, scientists ...
Breaking Biology News(10 mins):New discoveries could improve climate projections 2New management methods extend blackberry season 2Europe's flora is becoming impoverished 2Europe's flora is becoming impoverished 3HHS Secretary Sebelius Highlights Michigans MHA Keystone Center in Inaugural Health Care Success Story Report 51553 1HHS Secretary Sebelius Highlights Michigans MHA Keystone Center in Inaugural Health Care Success Story Report 51553 2HHS Secretary Sebelius Highlights Michigans MHA Keystone Center in Inaugural Health Care Success Story Report 51553 3HHS Secretary Sebelius Highlights Michigans MHA Keystone Center in Inaugural Health Care Success Story Report 51553 4Pelosi Remarks at Press Conference on Health Care Reform for the Middle Class 51551 1Pelosi Remarks at Press Conference on Health Care Reform for the Middle Class 51551 2Pelosi Remarks at Press Conference on Health Care Reform for the Middle Class 51551 3Pelosi Remarks at Press Conference on Health Care Reform for the Middle Class 51551 4Study estimates radiation dose cancer risk from coronary artery calcium screening 51549 1Study estimates radiation dose cancer risk from coronary artery calcium screening 51549 2Study estimates radiation dose cancer risk from coronary artery calcium screening 51549 3
... a gene enhancer, known as HACNS1, that may have contributed ... possibly also modifications in the ankle or foot that allow ... published in Science on Sept. 5, 2008. , ... existence of human-specific gene enhancers, which are switches near genes ...
... tuna population? Can we compute how to transition ... Those and other questions will be tackled by ... scientists affiliated with Cornell University,s new Institute for ... grant from the National Science Foundation (NSF). This ...
... development of powerful supercomputers capable of analyzing decades ... mark a technological milestone capable of bringing comprehensive ... Researchers at the University of Miami,s Rosenstiel School ... (National Center for Atmospheric Research), COLA (Center for ...
Other Biology News:Gene enhancer in evolution of human opposable thumb 2Gene enhancer in evolution of human opposable thumb 3Cornell gets $10 million NSF grant to establish new sustainability institute 2Petascale climate modeling heats up at University of Miami 2Petascale climate modeling heats up at University of Miami 3
Desmosomal Protein Immunogen: Full length, native protein purified from human epidermal keratins. Storage: -20 C, Avoid Freeze/Thaw Cycles...
PPIF Antibody...
Anti-ADAM-12 (Meltrin Alpha); amino terminal region; rabbit host...
Dual Color Mouse anti-Human Anti-Kappa FITC/CD19 PE Class: Antibody Product Group: Immunogluobulin...
Biology Products: